 | This article needs additional citations for verification. (January 2015) |
 | |
| Formerly | G.F.Mersons Limited, Ethicon Suture Laboratories |
|---|---|
| Company type | Subsidiary |
| Industry | Surgical systems and instruments |
| Founded | 1915, in Edinburgh, Scotland |
| Founder | George F. Merson |
| Headquarters | Bridgewater, New Jersey and Cincinnati, Ohio[1] |
Area served | Worldwide |
Key people | Michael Del Prado (chairman)[2] Andrew Ekdahl (president) |
| Products | Prolene, Monocryl, Vicryl, Ethilon, Gynecare |
| Revenue | $4.87 billion (sales)[3] (2011) |
Number of employees | 11,000 |
| Parent | Johnson & Johnson |
| Website | ethicon |
Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line.
Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide.[citation needed] In the United States, the market share is approximately 80%.[citation needed]
Ethicon conducts business in 52 countries.
- ^ "Locations around the world". Ethicon U.S. Retrieved 25 January 2016.
- ^ Perriello, Brad (22 May 2014). "J&J's pipeline includes 30 'major' medical devices and a surgical robot". MassDevice. Retrieved 25 January 2016.
- ^ "Management's Discussion and Analysis of Results of Operations and Financial Condition" (PDF). Johnson & Johnson. 2011. p. 29. Archived from the original (PDF) on 2 February 2016. Retrieved 25 January 2016.